Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design

Abstract: With the event of new Molecular targets, clinical trial design requirements to perform these trials are changing. This paper discusses some of the considerations that need to be taken into account when designing a trial, including those trials that assess combinations of targets. [Copyright &y& Elsevier]